Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Cancer: Breast -
FDA panel backs mentor silicone breast implants FDA panel backs mentor silicone breast implants

FDA panel backs mentor silicone breast implants

Cancer: BreastApr 14, 2005

A U.S. advisory panel on Wednesday urged approval for Mentor Corp.‘s silicone breast implants, a recommendation that could end 13-year-old restrictions sparked by concerns about the health risks when silicone leaks.

The 7-2 endorsement from the Food and Drug Administration advisory panel was a surprise following the committee’s 5-4 rejection a day earlier of Inamed Corp.‘s silicone implants.

“They’re not the same device,” said panel member Stephen Li, president of Medical Device Testing and Innovations, noting that Mentor’s implants had an “extremely low rupture rate” and impressive testing on device fatigue.

“The statistics and the follow-up were excellent, and we didn’t have nearly the questions on this application as we did on (Inamed’s),” Li said.

Mentor shares rose 12 percent in after-hours trading, while Inamed shares fell 5 percent.

The FDA will consider the panel’s input as it decides whether to approve more widespread use of silicone implants. Concerns about potential links between leaking silicone and disabling diseases prompted officials to ban the devices for most women in 1992.

The agency typically follows its panels’ advice, but 15 months ago it overruled a recommendation for approval of an earlier Inamed bid for silicone breast implants.

Final FDA approval of Mentor’s implants “is by no means a slam dunk. ... The end result won’t be known for some time,” said Amit Hazan, an analyst at SunTrust Robinson Humphrey.

If the FDA decides to approve Mentor’s application, the company should monitor some women for implant ruptures for 10 years and meet other conditions, the panel said. Also, women considering implants should get consent forms detailing what is, and what is not, known about implant risks.

Many women and plastic surgeons say silicone implants look and feel more natural than saline breast implants - the only option for most U.S. women since 1992.

Implant makers also say today’s silicone implants are more durable than older versions, and the gel is stickier and less likely to migrate.

Studies have failed to find a connection between silicone implants and Rheumatoid Arthritis, lupus and other chronic diseases that many women tie to the devices.

But panel member Brent Blumenstein said he was concerned that some women studied by Mentor reported exhaustion, joint pain and other possible symptoms of chronic diseases.

“In short, there’s too much uncertainty,” he said.

Makers admit implants can cause pain and other local complications, and they can break and require new operations to replace them. Mentor said a study of about 400 women showed 1 percent of implants broke over three years. None of the ruptures caused problems, and were detected by MRI scans. Other research showed no ruptures before seven years, Mentor said.

The ruling in favor of Mentor was a shock to rival Inamed, said Dan Cohen, Inamed’s vice president of global government and corporate affairs.

“I am stunned and amazed by the bizarre decision by a small number of panel members who yesterday demanded longer-term data and today accepted shorter-term data,” Cohen said.

Inamed’s main study followed patients for three to four years, while Mentor’s main study tracked women for two to three years.

In the United States, only breast cancer survivors and others needing reconstruction or implant replacements can now receive silicone implants, through clinical trials.

After closing up 2.2 percent to $35.33 in regular trading on the New York Stock Exchange, Mentor shares gained 12 percent to $39.45 a share on the Inet electronic brokerage.

Inamed shares, which closed down 4.4 percent at $63.51 on Nasdaq, fell 5 percent to $60.30 after hours on Inet. Inamed is being acquired by Medicis Pharmaceutical Corp.

Provided by ArmMed Media
Revision date: June 21, 2011
Last revised: by Andrew G. Epstein, M.D.

FDA panel backs mentor silicone breast implants Bookmark this! FDA panel backs mentor silicone breast implants

RELATED STORIES:

We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids. Commenting is not available in this weblog entry.

   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net


Health Centers







Diabetes

















Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback


Add to Yahoo RSS News Feed



Google Reader




Syndicate


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.